Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Salgado

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP Tarantino, G Viale, M F Press, et al.
ESMO Open|August 15, 2022
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignmentJ Thouvenin, C Van Marcke, L Decoster, et al.
Clinical Neurology and Neurosurgery|December 17, 2010
The Brazilian database on pregnancy in multiple sclerosisA Finkelsztejn, Y D Fragoso, M L B Ferreira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2023
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636]D M Vega, L M Yee, L M McShane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 4, 2021
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization ProjectD M Vega, L M Yee, L M McShane, et al.
ESMO Open|March 7, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancerL W de Boo, K Jóźwiak, N D Ter Hoeve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survivalY Wang, D Drubay, S F Jonas, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP Tarantino, G Viale, M F Press, et al.
ESMO Open|August 15, 2022
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignmentJ Thouvenin, C Van Marcke, L Decoster, et al.
Clinical Neurology and Neurosurgery|December 17, 2010
The Brazilian database on pregnancy in multiple sclerosisA Finkelsztejn, Y D Fragoso, M L B Ferreira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2023
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636]D M Vega, L M Yee, L M McShane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 4, 2021
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization ProjectD M Vega, L M Yee, L M McShane, et al.
ESMO Open|March 7, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancerL W de Boo, K Jóźwiak, N D Ter Hoeve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survivalY Wang, D Drubay, S F Jonas, et al.
Pageof 22